According to Publisher, the Global Auto Injectors Market is accounted for $1.10 billion in 2015 and is expected to reach $3.78 billion by 2022 growing at a CAGR of 19.42%. As large number of patients are opting for self administered treatment and care there is a flawless increase in use of Auto Injectors. Moreover, the high prevailing patients of anaphylaxis had presented a huge demand for the market which seems as pertaining factor behind the market growth. At the same time high cost and need for utmost care are some of the factors hampering the market.
Prefilled Syringes in primary drug container segment seems to be predominant in market segment because of the dramatic effect on the way injectable drugs are developed, prescribed and administered. Anaphylaxis in the therapeutic application segment will be dominant throughout the forecast period, as more people are allergic and nauseous. While North America being the largest market, Asia pacific hails as fastest growing because of channeling investments into China and India and improving consumer awareness through marketing campaigns.
For more information http://www.reportsweb.com/auto-injectors-global-market-outlook-2015-2022
Some of the major key players of the market are Unilife Corporation, Novartis International AG, Becton, Dickinson and Company, Antares Pharma, Inc., Mylan, Inc., Adamis Pharmaceuticals Corp, Hospira Inc, Scandinavian Health Limited (SHL) Group, Sanofi SA, Itelliject Inc , Pfizer, Inc., Lincoln Medical Ltd, Ypsomed Holdings AG, ALK Abello, Teva Pharmaceuticals Ltd and Biogen Idec, Inc.
-Product Specific Autoinjectors
-Manual Injection Autoinjectors
-Variable Dose Autoinjectors
-Automated Injection Autoinjectors
Product Types Covered:
Therapeutic Applications covered:
-Other Therapeutic Application
Primary Drug Containers Covered:
-Single Chamber Cartridge
-Dual Chamber Cartridge
-Plastic Prefilled Syringes
-Glass Prefilled Syringes
-Rest of Europe
-Rest of Asia Pacific
- Rest of the World
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001322797/sample
11 Company Profiling
11.1 Unilife Corporation
11.2 Novartis International AG
11.3 Becton, Dickinson and Company
11.4 Antares Pharma, Inc.,
11.5 Mylan, Inc.
11.6 Adamis Pharmaceuticals Corp
11.7 Hospira Inc
11.8 Scandinavian Health Limited (SHL) Group
11.9 Sanofi SA
11.10 Itelliject Inc
11.11 Pfizer, Inc.
11.12 Lincoln Medical Ltd
11.13 Ypsomed Holdings AG
11.14 ALK Abello
11.15 Teva Pharmaceuticals Ltd
11.16 Biogen Idec, Inc.
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001322797/buying